Portable ultrasound vendor SonoSite topped the $10 million mark in revenues in its first year since being spun off by ATL. Not surprisingly, the bulk of those revenues came in the fourth quarter (end-December), following launch of the Bothell, WA-based
Portable ultrasound vendor SonoSite topped the $10 million mark in revenues in its first year since being spun off by ATL. Not surprisingly, the bulk of those revenues came in the fourth quarter (end-December), following launch of the Bothell, WA-based companys first two commercial product platforms, the SonoSite 180 hand-held ultrasound system and the SonoHeart hand-held echocardiography system (SCAN 9/29/99 and 1/12/00). SonoSite began shipping SonoHeart this month.
Despite revenues of $9.4 million for the fourth quarter and $10.1 million for the year, SonoSite still reported hefty losses at years end: Losses for the year were $21.6 million, compared to $13 million for 1998. This was due in part to increases in operating expenses related to product and personnel ramp-up in support of the companys new product lines. Fourth-quarter losses reflect the companys new revenue streams, however; losses for the quarter were $3.2 million, compared to losses of $4.7 million for the fourth quarter of 1998.
FDA Clears Virtually Helium-Free 1.5T MRI System from Siemens Healthineers
June 26th 2025Offering a cost- and resource-saving DryCool magnet technology, the Magnetom Flow.Ace MRI system reportedly requires 0.7 liters of liquid helium for cooling over the lifetime of the device in contrast to over 1,000 liters commonly utilized with conventional MRI platforms.
SNMMI: Botox May Facilitate Relief from Dry Mouth Side Effect of PSMA-Targeted Radiopharmaceuticals
June 25th 2025For patients being treated with radiopharmaceutical agents for metastatic prostate cancer, the combination of botulinum toxin and an anti-nausea patch led to a 30 percent reduction in PSMA uptake in the salivary glands, according to preliminary research findings presented at the SNMMI conference.